Physician
Oncology
Dr. Robert F. Ozols, MD
|
|
Give Review
Robert Ozols practices Oncology. He graduated from University of Rochester School of Medicine and Dentistry. He has 3 awards "Fellow (FASCO)", "Elected Member" and "Whos Who in Medicine and Healthcare". Robert Ozols is also published. He has 27 publications published. The lastest publication: "The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group s...'
Publications
- The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group s...
- CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study.
- The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study.
- Gynecologic Oncology Group (GOG-USA) trials in ovarian cancer.
- Ovarian cancer: is dose intensity dead?
- RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model.
- The management of recurrent ovarian cancer.
- Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations.
- Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
- Intraperitoneal chemotherapy for ovarian cancer.
- Systemic therapy for ovarian cancer: current status and new treatments.
- Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gyne...
- Gemcitabine and carboplatin in second-line ovarian cancer.
- Counterpoint: Intraperitoneal chemotherapy: an investigational treatment in ovarian cancer.
- Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
- Symptoms of ovarian cancer--where to set the bar?
- Focus on epithelial ovarian cancer.
- Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer.
- NICE guidelines for ovarian cancer: recommendations versus standard care.
- Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
- Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit.
- Specific keynote: chemoprevention of ovarian cancer: the journey begins.
- Update on the management of ovarian cancer.
- Recurrent ovarian cancer: evidence-based treatment.
- The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics.
- Future directions in the treatment of ovarian cancer.
Schools
University Of Rochester School Of Medicine and Dentistry
Dartmouth Hitchcock Hospital
National Cancer Institute
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Fellow (FASCO)
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Dartmouth-Hitchcock Medical Center -
University of Rochester School of Medicine and Dentistry
Helpful Reviews
Similar Doctors
|
|
Dr. Jonathan D. Cheng, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald E. Tsai, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Martin P. Carroll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Bookman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Bajor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve C. Goldstein, MD |
|
|
Dr. Naomi S. Haas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aruna Padmanabhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared M. Weiss, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew H. Carabasi, MD
This Doctor is OpenDoctor Recommended.
|